PMID: 8976642
Neuroinflammation and infection: molecular mechanisms associated with dysfunction of neurovascular unit
Reported adverse effects are mostly mild and transient, including injection-site reactions (pain, redness, swelling, or itching), temporary headache, nausea, dizziness or lightheadedness, increased appetite, mild fluid retention (peripheral edema), transient joint pain or stiffness, fatigue, and mild flu-like symptoms (low-grade fever, chills, myalgia)
The medication is self-injected subcutaneously once a week, and any questions about dosing or side effects are handled through messages with the provider
This includes regular monitoring, medication management, nutritional guidance, and support for the emotional aspects of dealing with the condition
Weight loss outcomes illustrate these differences clearly: berberine supplementation typically results in 24 pounds of weight loss over several months, while GLP-1 therapy produces an average of 1520 pounds or more within the same timeframe in clinical populations
